Dr Reddy’s Laboratories has launched its over-the-counter (OTC) fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release tablets 60 mg / 120 mg, a bioequivalent generic version of ...
ALLEGAN, Mich., April 13, 2011 /PRNewswire/ -- Perrigo (Nasdaq: PRGO;TASE) today announced that its partner, Teva Pharmaceutical Industries, Ltd. (Nasdaq: TEVA), has received final OTC approval to ...
Dr. Reddy’s is offering the first to market over-the-counter fexofenadine HCl 180 mg and pseudoephedrine HCl 240 mg extended-release tablets, a store-brand equivalent of Aventis’s Allegra-D 24 HR.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback